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ABSTRACT The current article describes a new two-dimensional l-dynamics method to include proton tautomerism in
continuous constant pH molecular dynamics (CPHMD) simulations. The two-dimensional l-dynamics framework is used to
devise a tautomeric state titration model for the CPHMD simulations involving carboxyl and histidine residues. Combined with
the GBSW implicit solvent model, the new method is tested on titration simulations of blocked histidine and aspartic acid as well
as two benchmark proteins, turkey ovomucoid third domain (OMTKY3) and ribonuclease A (RNase A). A detailed analysis of
the errors inherent to the CPHMD methodology as well as those due to the underlying solvation model is given. The average
absolute error for the computed pKa values in OMTKY3 is 1.0 pK unit. In RNase A the average absolute errors for the carboxyl
and histidine residues are 1.6 and 0.6 pK units, respectively. In contrast to the previous work, the new model predicts the correct
sign for all the pKa shifts, but one, in the benchmark proteins. The predictions of the tautomeric states of His
12 and His48 and the
conformational states of His48 and His119 are in agreement with experiment. Based on the simulations of OMTKY3 and RNase
A, the current work has demonstrated the capability of the CPHMD technique in revealing pH-coupled conformational dynamics
of protein side chains.
INTRODUCTION
The stability and function of proteins are dependent on the
environmental pH (1). Well-known examples of pH-de-
pendent biological processes include ﬁbril formation from
one of 16 normally soluble and functional human amyloido-
genic proteins such as amyloid b-peptides, transthyretin, and
prion proteins (2,3), membrane insertion of diphtheria toxin
(4) and inﬂuenza virus hemagglutinin (5), and proton
gradient-driven ATP synthesis (6), as well as the catalytic
pathway of dihydrofolate reductase (7). In a conventional
molecular dynamics (MD) simulation the protonation state
of the protein is preset and kept ﬁxed according to the known
pKa values of the ionizable side chains. Two problems arise
from the assumption of static protonation. First, because the
pKa value of an ionizable side chain is typically unknown in
its protein environment one has to resort to the value of an
isolated amino acid (model pKa), which sometimes deviates
signiﬁcantly from the value in the protein. Second, the
protonation/deprotonation of an ionizable side chain is a
process that is coupled to the dynamics of the local envi-
ronment. By artiﬁcially ﬁxing the protonation state in a MD
simulation, the dynamics of the ionization equilibrium is
neglected, thereby precluding detailed understanding of the
speciﬁc interactions that give rise to the pH-coupled bio-
logical phenomena.
The history of pH-coupled molecular dynamics is rela-
tively short. A decade ago, Mertz and Pettitt (8) demon-
strated a titration simulation of acetic acid using an open
system Hamiltonian. Sham et al. (9) showed that the pKa
values of lysozyme can be accurately modeled using the
protein dipoles Langevin dipoles model, which treats the
protein relaxation in the microscopic framework of the lin-
ear response approximation. In more recent years, several
simulation techniques that allow pH-coupled molecular
dynamics have emerged. Most of these techniques are based
on the combination of molecular dynamics (MD) and Monte
Carlo (MC) sampling of protonation states, with the major
differences being the solvent representation and the way the
free energy change accompanying the switch of the pro-
tonation state is computed. In the methods of Baptista et al.
(10,11) and Bu¨rgi et al. (12), explicit solvent is used to
generate the MD trajectory. While the method of Bu¨rgi et al.
(12) utilizes thermodynamic integration to determine the
protonation free energy change of a single residue, the
method of Baptista et al. (11) makes use of static pKa
calculations based on the implicit solvent Poisson-Boltz-
mann (PB) model. More recently, these hybrid MD/MC
schemes were extended to implicit solvent simulations:
Dlugosz and Antosiewicz (13) make use of the analytic
continuum electrostatic and the PB models for generating the
MD trajectory and evaluating the protonation free energy
change respectively; Mongan et al. (14) use the Generalized-
Born (GB) model throughout the simulation.
There are several issues that have to be dealt with in the
hybrid MD/MC constant pH simulation schemes. First, the
periodic abrupt switch in the protonation state introduces
a discontinuity in energy and force, which may result in
conformational and energetic instabilities. Second, since
only one protonation site at an instantaneous conformation of
the protein is randomly chosen during a MC step, sampling
convergence with regard to protonation and conformational
states may be slow for proteins containing many ionizable
sites. Third, some issues remain relating to the determination
of the free energy change accompanying the protonation
Submitted February 15, 2005, and accepted for publication April 20, 2005.
Address reprint requests to Jana Khandogin, Tel.: 858-784-8070; Fax:
858-784-8688; E-mail: janakhan@scripps.edu.
 2005 by the Biophysical Society
0006-3495/05/07/141/17 $2.00 doi: 10.1529/biophysj.105.061341
Biophysical Journal Volume 89 July 2005 141–157 141
state switch. In the methods of Baptista et al. (11) and
Dlugosz and Antosiewicz (13), which use the instantaneous
protein conformation for the evaluation of the free energy
difference, a somewhat ad hoc protein dielectric constant has
to be chosen to mediate the electrostatic interactions in the
otherwise static protein conﬁguration. On the other hand, in
the method of Bu¨rgi et al. (12), which employs a short run
(tens of picoseconds) of free energy simulation such as
thermodynamic integration, the increased computational cost
associated with the large of number of MC steps has to be
considered.
In contrast to the discrete methods, the methods of
Bo¨rjesson and Hu¨nenberger (15), and of Lee et al. (16) are
based on simultaneous propagation of continuous titration
and conformational degrees of freedom. Both approaches
use linear combinations of the deprotonated and protonated
states to model nonbonded interactions. Although the method
of Bo¨rjesson and Hu¨nenberger relies completely upon
explicit solvent simulation and uses the l-variable to re-
present the extent of protonation for each ionizable site
(15), the method of Lee et al., which has its roots in the
l-dynamics method (17), utilizes the implicit GB solvent
model (18) and attaches physical meaning only to the end
points. To minimize the possible distortion due to the
unphysical mixed states that are nonetheless necessary for
the transition between the end-point states, an artiﬁcial
titration barrier is utilized in the continuous pH molecular
dynamics method (CPHMD) of Lee et al. (16), which serves
to prolong the residency time of the end-point states. The
combined advantage of a stable dynamics trajectory and low
computational cost makes the CPHMD approach of Lee et al.
particularly suitable and attractive as a means of exploring
pH-dependent conformational processes in proteins.
One prerequisite for the application of the constant pH
molecular dynamics method to pH-coupled protein dynam-
ics is reasonable accuracy in the prediction of protonation
states or pKa values for ionizable side chains. Among the
aforementioned methods, so far, only three have been tested
on proteins. While two of them, the hybrid MD/MC methods
of Bu¨rgi et al. (12) and Mongan et al. (14) were tested only
on hen egg white lysozyme, the CPHMDmethod of Lee et al.
(16) was tested on four different proteins, including turkey
ovomucoid third domain (OMTKY3), bovine pancreatic
ribonuclease A (RNase A), bovine trypsin inhibitor, and hen
egg white lysozyme. In this pilot study, the total average
absolute error over all proteins was 1.6 pK units (16).
A quick survey of the computed pKa values in the work of
Lee et al. (16) reveals that the average absolute error is
largest for the histidine groups (3.2 pK units), followed by
the carboxyl (1.6 pK units) and amino groups (1.2 pK units).
One obvious reason for the increased errors in predicting the
pKa of histidine is the simplistic treatment of proton iso-
merism, in which case the imidazole ring is split into two
titration halves involving the ND1 and NE2 sites with an
added penalty potential to prevent double deprotonation
(16). This model will be referred to as the split model in the
rest of the article. In a constant pH MD simulation, the split
model gives rise to two problems. First, since the two
titration halves have common atoms, proper atomic charge
states cannot be assigned to the neutral histidine tautomers,
HSE (protonated on NE2) and HSD (protonated on ND1).
Second, the penalty function to eliminate double deproto-
nated histidine, Kl1l2, introduces an undesired biasing
force.
In the present work, a new tautomeric state titration model,
also referred to as the double-site model, is developed. This
model allows simultaneous titration at two competing pro-
tonation sites, such as the NE2 and ND1 atoms in histidine.
The new model utilizes an additional dynamic variable that is
treated on an equal footing to the titration degrees of freedom
to control the tautomer interconversion process. Besides
histidine, which exhibits the true proton tautomerism in
solution, carboxyl groups such as Asp, Glu, and the C-ter-
minus can be considered as having two tautomeric pro-
tonation sites, since the exchange of two titrating oxygens
due to rotation around the single bond is slow on the routine
MD simulation timescale. In essence, our tautomeric state
titration model is a two-dimensional l-dynamics approach
that can, in general, be extended to additional dimensions.
For example, the titration of amino groups can be viewed as a
tautomeric equilibrium among three states and can be dealt
with by constructing a three-dimensional model. However,
since most amino groups do not exhibit large pKa shifts, as
seen for example in hen egg white lysozyme, the necessity
for the development of a more sophisticated model is
questionable. In fact, as mentioned previously, the errors in
the computed pKa values for amino groups are the smallest
in the existing CPHMD method of Lee et al. (16) Finally,
it is worthwhile noting that although the two-dimensional
l-dynamics approach is applied to the coupled protonation
and tautomeric interconversion equilibria in the present
work, the approach is general and can be applied to other
problems.
The CPHMD method is further extended in the present
study to incorporate the newly developed GBSW implicit
solvent model (19) because of the added capability of this
method for simulations in a membrane environment (20) and
for the greater computational efﬁciency (21) relative to the
GBMV method (18) that was implemented in the original
CPHMD code. Since the accuracy of the CPHMD simu-
lations is intimately linked to conformational sampling and
the underlying implicit solvent model, the applications of
CPHMD will beneﬁt from the improved sampling schemes
as well as the solvent model.
The purpose of the present work is to extend and improve
the existing CPHMDmethod developed by Lee et al. (16). In
their work (16) it was noted that CPHMD simulations using
the GBMV solvent model gave an overestimation of 0.3 pK
units for the blocked aspartic acid. This has prompted us to
examine the details of the titration simulations of model
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compounds aimed at understanding the convergence behav-
ior and errors inherent to the CPHMD methodology. Other
errors in the prediction of protein ionization equilibrium
arising from the force ﬁeld and implicit solvent model will be
explored by revisiting two proteins: OMTKY3 and RNase A.
Since the predictions of pKa shifts in the carboxyl and his-
tidine residues in these proteins proved particularly prob-
lematic in the previous work (16), they provide excellent test
beds for the tautomeric state model as well as the GBSW
solvent model.
The rest of the article is organized as follows. In the
Theory section, following a brief review of the CPHMD
methodology, the formalism of the two-dimensional l-dy-
namics approach is outlined and discussed for two special
cases where tautomerism manifests in either the protonated
or the deprotonated state. In Methods, the derivations of
model potential functions as well as the macroscopic pKa
values for the titration simulations involving histidine and
carboxyl side chains are given. Force-ﬁeld issues related to
the construction of the protonation state models are dis-
cussed. The last subsection in Methods details the simulation
protocol. In Results and Discussion, the convergence be-
havior and errors in the titration simulations of blocked
aspartic acid and histidine are discussed. The pKa values of
OMTKY3 and RNase A obtained from the CPHMD
simulations using the new model are analyzed and compared
to those from the previous work of Lee et al. (16), from the
static PB calculations and experimental data. The issues
related to the force ﬁeld and implicit solvation, as well as the
dynamic coupling between protonation and the local
conformation. The last section of the article draws
conclusions and makes suggestions for future directions of
research.
THEORY
Continuous constant pH molecular dynamics
To facilitate derivations and discussions of the new model,
we brieﬂy review the methodology of the continuous implicit
solvent constant pH molecular dynamics (CPHMD) (16). In
the CPHMD method, the protonation/deprotonation (titra-
tion) process at a protein titrating residue i is described by
a set of continuous coordinates,
li ¼ sin2ðuiÞ; i ¼ 1; n; (1)
the end points of which deﬁne the deprotonated (li ¼ 1) and
protonated states (li ¼ 0). Thus, the CPHMD simulation is
a special case of l-dynamics (17), where the l-variables
deﬁne the titration coordinates.
In classical simulations, the deprotonation free energy of
a protein side chain is obtained through modeling the dif-
ference between the free energy of deprotonating a side chain
in the protein environment and that in solvent. Since the latter
energy, namely, the deprotonation energy of a blocked amino
acid (model compound) in solvent, is experimentally acces-
sible, the deprotonation energy in the protein environment can
be obtained as
DGðproteinÞ ¼ DGclassðproteinÞ  DGclassðmodÞ
1DGexpðmodÞ; (2)
where DGexp(mod) is given as
DGexpðmodÞ ¼ ln 10 3 kBTðpKa  pHÞ; (3)
and the pKa value reﬂects the pH condition at which the
populations of protonated and deprotonated states are equal.
Based on the above considerations, the total potential
energy of the protein in the CPHMD simulation can be
written as
U
totðli; i ¼ 1; nÞ ¼ Uint1Unpolar1UvdWðli; i ¼ 1; nÞ
1Uelecðli; i ¼ 1; nÞ1UGBðli; i ¼ 1; nÞ  Umodðli; i ¼ 1; nÞ
1 +
n
i¼1
U
pHðliÞ  +
n
i¼1
U
barrðliÞ; (4)
where fli;i ¼ 1, ng is a set of titration coordinates for the n
titrating residues as deﬁned in Eq. 1. In Eq. 4, the two terms
are the protonation-independent internal (bonded) energy
and nonpolar solvation energy, and the rest are the
protonation-dependent nonbonded and biasing potential
energies.
The van der Waals energy for the interaction between the
titrating proton i and another atom j is given by
U˜
vdWði; jÞ ¼ ð1 liÞU
vdWði; jÞ j : other
ð1 liÞð1 ljÞUvdWði; jÞ j : titrating
;
(
(5)
whereUvdW(i, j) represents the protonation independent (full-
strength) van der Waals interaction energy. The protonation
dependence of the Coulomb and GB electrostatic energies
is incorporated through the atomic partial charges on the
titrating residue, which are linearly interpolated between the
values in the deprotonated and protonated states,
qi;a ¼ liqui;a1 ð1 liÞqpi;a (6)
where qi,a represents the partial charge of atom a on residue
i; and qui;a and q
p
i;a are the charges in the deprotonated and
protonated states, respectively.
The ﬁrst biasing potential Umod in Eq. 4 originates from
the term DGclass(mod) in Eq. 2 and is a potential of mean
force (PMF) along the l-coordinate. Due to the nature of the
nonbonded terms (Eq. 5 and Eq. 6), it is a quadratic function
of the titration coordinate,
U
modðliÞ ¼ Aiðli  BiÞ2; (7)
and can be obtained via thermodynamic integration. The
second biasing potential in Eq. 4 originates from the term
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DGexp(mod) in Eq. 2 and models the pH-dependence of the
deprotonation free energy. Thus,
U
pHðliÞ ¼ ln 10 3 kBT 3 liðpKaðiÞ  pHÞ; (8)
where pKa(i) is the pKa value of the titrating group i.
The last term in Eq. 4 is called a barrier potential,
U
barrðliÞ ¼ 4bi

li  1
2
2
; (9)
where bi is the barrier at the center of the titration coordinate.
The barrier potential does not alter the energy difference be-
tween the end-point states (l ¼ 0 or l ¼ 1) but serves as an
umbrella to prolong sampling time in the region of the end-
point coordinates. This is necessary because the electrostatic
and van der Waals interactions of the titrating residue associ-
ated with a mixed state (0 , l , 1) are unphysical.
Two-dimensional l-dynamics method
Tautomeric state model
As in most pKa calculations, the existing CPHMD method
assumes a particular protonating atom for residues that con-
tain multiple titration sites, such as histidine and carboxyl
groups. In what follows, a new model is introduced that re-
moves this bias and treats the titration of the proton tauto-
mers on an equal footing.
In the new model we assign an additional continuous co-
ordinate x, which offers control of interconversion between
the tautomeric states. This coordinate will be treated in the
same manner as the titration coordinate l. Thus, the titration
of histidine involves interconversion among three states,
which can be deﬁned in terms of the titration and tautomeric
coordinates as (0) for the doubly protonated state HSP;
(1,1) for the NE2-protonated state HSE; and (1,0) for the
ND1-protonated state HSD, where the ﬁrst number in the
parenthesis refers to the l-value and the second the x value
(Fig. 1 A). Notice that HSP can take on any x-value since
its energy is degenerate with respect to x. Analogously, the
three states in the titration of aspartic acid are deﬁned
as (1) for the deprotonated ASP; (0,1) for the OD1-
protonated state ASPP1; and (0,0) for the OD2-protonated
state ASPP2 (Fig. 1 B). Notice that ASP can take on any
value of x.
The acid-base and proton tautomeric equilibria of histidine
and aspartic acid are two special cases of two-dimensional
l-dynamics, where the two l-driven processes are de-
generate at one end point (either l ¼ 0 or l ¼ 1) and are
coupled to each other via the x-coordinate at the other end
point (either l ¼ 1 or l ¼ 0). Despite the formal identity of
the two cases, somewhat different expressions have to be
derived for the l- and x-dependent potential energy functions
(the second and third lines in Eq. 4). In our remaining
discussions we will refer to both cases as the deprotonated
(histidine) and protonated (aspartic acid) tautomerism.
Nonbonded interactions
Following the addition of the tautomeric state coordinate x,
the atomic charge on a titrating group can be written as a
linear combination of four charge states,
qi;a ¼ li½xiqi;að11Þ1 ð1 xiÞqi;að01Þ
1 ð1 liÞ½xiqi;að10Þ1 ð1 xiÞqi;að00Þ; (10)
where the values for the l- and x-coordinates are given in
parentheses. Since histidine has only one protonated state,
qi,a(01)¼ qi,a(00). Analogously, for aspartic acid, qi,a(11)¼
qi,a(10). Notice that Eq. 6 can be recovered from Eq. 10 if the
charge states of the tautomers are identical.
In the case of the deprotonated tautomerism (Fig. 1 A), the
van der Waals energy for the interaction of titrating atom i
and another atom j is given by
where the superscripts m and n indicate the nature of the
titrating atoms i and j, respectively. For example, in the
titration of histidine, a value of 1 is associatedwith the titrating
protonHE2and0 is associatedwithHD1. For a nontautomeric
titrating proton, a value of1 is assigned. Thus, the function
f m(xi) can be written as
f
mðxiÞ ¼
xi m ¼ 1
1 xi m ¼ 0
1 m ¼ 1
;
8><
>: (12)
where the function f n(xj) can be deﬁned analogously. Notice
that Eq. 5 can be recovered from Eq. 11 using the last deﬁ-
nition of fm(xi), or f
n(xi), in the absence of tautomerism.
In the case of the protonated tautomerism (Fig. 1 B), the
van der Waals energy is given by
U˜
vdWði; jÞ ¼ ð1 li f
mðxiÞÞUvdWði; jÞ j : other
ð1 li f mðxiÞÞð1 lj f nðxjÞÞUvdWði; jÞ j : titrating
;
(
(11)
U˜
vdWði; jÞ ¼ ð1 liÞf
mðxiÞUvdWði; jÞ j : other
ð1 liÞð1 ljÞf mðxiÞf nðxjÞUvdWði; jÞ j : titrating
;
(
(13)
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where the function f m(xi) (or f
n(xi)) m (or n) takes on the
value of 1 for the titrating proton HD1, 0 for HD2, and 1
for a nontautomeric titrating proton. Eq. 5 can again be
recovered from Eq. 13 in the absence of tautomerism.
Biasing potentials
In the presence of proton tautomerism, the pH-dependent po-
tential function becomes
U
pH ¼ ln 103kBT3li½xiðpK1a  pHÞ1 ð1 xiÞðpK2a  pHÞ;
(14)
where pK1a and pK
2
a refer to the microscopic pKa values for
the two titration sites. To suppress the population of mixed
states in terms of x, a tautomer interconversion barrier po-
tential in analogy to the titration barrier potential (Eq. 9) is
applied to each coordinate xi.
The functional form of the model potential in terms of
the titration and tautomeric interconversion coordinates is
determined by the functional forms of the Coulomb, GB
electrostatic and van der Waals interaction energies. In the
absence of tautomerism this leads to a quadratic function
as mentioned earlier (Eq. 7). In the presence of proton
tautomerism the coupling between l and x results in a
complex functional form for the model potential. However,
since linear interpolation is used in the expressions for both
the atomic partial charges and van der Waals interaction
energy, the model potential function is expected to remain
quadratic in either the l- or x-variable.
Before attempting the derivation of the model potential
function in the two-dimensional coordinate space (l, x), it is
instructive to consider the scenarios where either the titration
or tautomeric interconversion coordinate is ﬁxed at one of its
end points. In the case of the deprotonated tautomerism, each
process (or equilibrium) displayed in Fig. 1 A, is associated
with a quadratic function. Since the energy of the protonated
form, HSP, is independent of x, the potential function at
HSP must be a constant. The following equations present the
boundary conditions for the model potential function,
U
modðli; 1Þ ¼ A1ðli  B1Þ2
Umodðli; 0Þ ¼ A0ðli  B0Þ2
U
modð1; xiÞ ¼ A10ðxi  B10Þ2
U
modð0; xiÞ ¼ 0; (15)
where A1, B1, A0, B0, A10, and B10 are the parameters in the
quadratic functions that describe the one-dimensional pro-
cesses and are related to each other through the relationship
DUmodðli ¼ 0/1; 1Þ  DUmodðli ¼ 0/1; 0Þ
¼ DUmodð1; xi ¼ 1/0Þ: (16)
In other words, the difference in the free energies of
deprotonation for HSP/HSE and HSP/HSD is the same
as the free energy of tautomer interconversion HSE/HSD.
We will show later that the model potential parameters can
be derived analytically by making use of the boundary con-
ditions given in Eq. 15. It should be noted that the model
potential function contains an arbitrary constant since the
difference deprotonation energy (see Eq. 2) is the interesting
quantity in this work. For the case of the protonated tautom-
erism, there exists an analogous set of equations that describes
the one-dimensional conditions.
Since the model potential function is quadratic in either
the l- or x-variable, a general expression in the form of a bi-
variate polynomial containing eight parameters can be found:
U
modðli; xiÞ ¼ a0l2i x2i 1 a1l2i xi1 a2lix2i 1 a3lixi
1 a4l
2
i 1 a5x
2
i 1 a6li1 a7xi: (17)
In the case where tautomerism exists for one protonation
form (either Umod(0, xi) ¼ 0 or Umod(1, xi) ¼ 0) there are, at
most, six nonvanishing parameters in Eq. 17. One way to
identify the nonzero terms is to follow the procedure below,
Step 1, at ﬁxed values of x, obtain parameters for the
quadratic function of l: f(l;x) ¼ A(x)[l – B(x)]2;
Step 2, ﬁt the parameters A(x) and B(x) to the second-
order polynomial: b1x
2 1 b2x 1 b3;
Step 3, at ﬁxed values of l, obtain parameters for the
quadratic function of x: f(x;l) ¼ A(l)[x  B(l)]2; and
Step 4, ﬁt the parameters A(l) and B(l) to the second-
order polynomial: c1l
2 1 c2l 1 c3,
FIGURE 1 Acid-base and proton tautomeric equilibria of histidine (A)
and aspartic acid (B).
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where some of the coefﬁcients in the polynomial obtained in
Steps 2 and 3 vanish. By matching the same order terms in
f(l;x) and f(x;l) and utilizing the difference in the l- and
x-dependent polynomial forms (Steps 2 and 3), the nonzero
terms in the general form of the model potential (Eq. 17) can
be determined. A detailed derivation of the parameters in the
model potential functions for the deprotonated (histidine)
and protonated tautomeric (carboxylic acid) cases is given in
the Supplementary Material.
METHODS
Macroscopic pKa values from the tautomeric
state model
In the CPHMD simulation, the fractional population of unprotonated states
(unprotonated fraction) for a titrating residue is given as
S
unprot ¼ r
unprot
r
unprot1 rprot
 N
unprot
N
unprot1Nprot
; (18)
where runprot and rprot are the probabilities for the unprotonated and pro-
tonated states, which can be related to the number of times unprotonated
(Nunprot) and protonated (Nprot) states are observed in the simulation, re-
spectively.
Since bounded continuous coordinates are utilized for the propagation of
protonation and tautomeric states, some cutoff values have to be used to deﬁne
the pure protonation and tautomeric states. In this work we extend the
convention employed previously by Lee et al. (16) to include the tautomeric
states. Thus, the number of unprotonated and protonated states are deﬁned as
N
unprot ¼ Nðl. 0:9; x, 0:1 or x. 0:9Þ
N
prot ¼ Nðl. 0:1; x, 0:1 or x. 0:9Þ: (19)
Notice that the mixed tautomeric states (0.1 , x , 0.9) are discarded from
the above deﬁnition, although the value of x is irrelevant for the doubly
protonated state of histidine (Fig. 1 A) or the deprotonated carboxylate
residue (Fig. 1 B). However, since the protonation states in the simulation are
deﬁned through some cutoff values, their energies do depend on x. There-
fore, the mixed tautomeric states are not included in the statistics.
To obtain the pKa value for a titrating residue, the unprotonated fractions
at different pH were used to ﬁt to the generalized form of the Henderson-
Hasselbach equation,
S
unprot ¼ 1
11 10nðpKapHÞ
; (20)
where n is the Hill coefﬁcient. The deviation of the value of n from unity
reﬂects the degree of cooperativity (coupling) between groups that interact
and ionize over the same pH range. In this work the Hill coefﬁcient is in-
cluded into the ﬁtting procedure to account for the couplings between ion-
izable sites. It is noted, however, that the computed pKa is only marginally
affected by the value of n.
Given the equilibrium constants k1 and k2 for the microscopic depro-
tonation processes HSP/ HSE, and HSP/ HSD, respectively (Fig. 1 A),
the equilibrium constant k for the macroscopic deprotonation of histidine
is given as
k ¼ k11 k2: (21)
Thus, by applying the deﬁnition of pKa (pKa ¼log10k, the macroscopic
pKa for the histidine titration can be related to the microscopic counterparts,
pK1 and pK2 by
pKa ¼ log10ð10pK1 1 10pK2Þ: (22)
Provided the reference microscopic value of 6.6 (pK1) and 7.0 (pK2) for the
ND1- and NE2-titration in the blocked histidine, respectively, Eq. 22 leads
to a macroscopic pKa of 6.45.
Given the equilibrium constants k1 and k2 for the microscopic depro-
tonation processes of aspartic acid (Fig. 1B), the equilibriumconstant k for the
macroscopic deprotonation can be written as
k ¼ 1= 1
k1
1
1
k2
 
; (23)
which leads to the relation
pKa ¼ log10ð10pK1 1 10pK2Þ: (24)
Assuming a reference microscopic value 4.0 for both pK1 and pK2, Eq. 24
leads to a macroscopic pKa of 4.3. Since the experimental macroscopic pKa
for the blocked aspartic acid is 4.0, a postcorrection is made (see later
discussions).
Protonation state models
In the CPHMD method, the transition between protonation states of a
titrating residue is modeled by linear attenuation of nonbonded energies
while keeping the topology, bonded, and van der Waals parameters of the
residue intact. Consequently, in a deprotonated state, the titrating hydrogen
atom becomes a dummy atom with zero charge and has no van der Waals
interaction with other atoms. This strategy is therefore similar to the single-
topology scheme in free energy simulations.
The titration of histidine in the tautomeric state model is based on the
topology and associated bonded as well as van der Waals parameters of the
doubly protonated histidine (residue type HSP in CHARMM). The atomic
charges of the three protonation states (Fig. 1 A) are identical to those in
CHARMM type HSP, HSE, and HSD, respectively. In the intermediate or
mixed states, the nonbonded interactions are computed by linear in-
terpolation via the l- and x-variables as described in the Theory section.
For the titrations of the carboxyl residue, a new CHARMM residue type is
constructed based on carboxylic acid such that a second hydrogen atom is
placed on the unprotonatedoxygen. Let us consider aspartic acid. The titration
of aspartic acid in the tautomeric statemodel is based on the topology, bonded
and van der Waals parameters of the new hybrid residue, which will be
referenced as ASDP. The force-ﬁeld parameters of ASDP differ from those of
aspartic acid (CHARMM type ASPP, protonated on OD2) in that the CG,
OD1, andOD2 atoms are assignedwith the corresponding bonded parameters
of the deprotonated aspartate (CHARMM type ASP) whereas the titrating
(dummy) hydrogens HD1 and HD2 are assigned with the bonded parameters
of the aspartic acid (CHARMM type ASPP). From the hybrid residue ASDP,
three protonation states are constructed: the deprotonated stateASP,with both
dummy hydrogens uncharged and having no van der Waals interactions; two
protonated states (ASP1 and ASP2), with either HD1 or HD2 charged and
having van derWaals interactions. Notice that there is no interaction between
the two dummy hydrogens due to the unphysical nature of the doubly pro-
tonated state, although both hydrogens are allowed to interact with other
atoms in a mixed state.
One drawback of the dummy atom representation of the protonation
states for the carboxyl residues is that the uncharged dummy hydrogen can
lose the ability to gain charge once it is rotated to the anti position (16,14).
A remedy used previously by Lee et al. (16) was to signiﬁcantly lower the
barrier to the rotation around the carboxylate bond such that the rotation
back to the syn position is facilitated. A caveat is, however, that this can lead
to nonnative hydrogen bonds as a result of stabilization of the unphysical
out-of-plane conformations (16). The syn conformation is thermodynami-
cally more favorable relative to the anti one by ;2.8 kcal/mol, according
to a solid-state NMR experiment (22). Quantum calculations and molecular
dynamics simulations have shown a free energy difference of ;1.6–1.9
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kcal/mol (22,14). On the basis of these considerations, our solution is to
kinetically disfavor the anti position by raising the C-O bond rotation barrier
from 4.1 to 6.0 kcal/mol and placing the dummy carboxyl hydrogens at the
syn positions at the beginning of the simulation.
Simulation protocol
All of the simulations described in this work were performed using the
PHMD module with the all-atom CHARMM22 force ﬁeld (24) for proteins
including the dihedral cross term corrections (CMAP) (25) and the GBSW
solvent model (20,19) in the CHARMM molecular dynamics program (26).
The original PHMD module (16), in which the CPHMD method was imple-
mented, was extended to allow tautomeric state titrations and to include pH-
dependent solvation energy and force with the GBSW solvent model. The
SHAKE algorithm was applied to hydrogen bonds and angles, such that
a timestep of 2 fs could be used. A 22 A˚ distance truncation was applied to
both the nonbonded and GB energy/force evaluations. All simulations uti-
lized a Nose´-Hoover thermostat to ensure a canonical distribution of atomic
velocities at a constant temperature of 298 K. For the GB calculations, a
smoothing length of 0.6 A˚ at the dielectric boundary with 24 radial inte-
gration points up to 20 A˚ and 38 angular integration points were used. The
nonpolar solvation energy was computed using the surface tension coef-
ﬁcient of 0.03 kcal mol1 A˚2.
For the propagation of titration and tautomer interconversion coordinates,
the velocities of l and x were coupled to a three-mass (30, 50, and 70 amu)
Nose´-Hoover chain (27,28) to ensure a canonical distribution at the target
temperature of 298 K. Unless otherwise speciﬁed, the default initial velocity
seed was used for the simulation. Model compounds used in this work were
the blocked amino acids obtained by acetylating the N-terminus and
amidating the C-terminus. To obtain the one-dimensional model potential
functions, thermodynamic integrations based on 1-ns MD simulations (100
ps equilibration and 1 ns production) were performed at several ﬁxed points
along the titration or tautomer interconversion coordinates, as described
previously (16). In single-site titration simulations, a titration barrier of
1.25 kcal mol1 was used (16). For double-site titrations, a titration barrier
of 1.75 and a tautomer interconversion barrier of 2.75 kcal mol1 for the
carboxyl groups and 2.5 kcal mol1 for histidines were applied, which in
general keeps the fractional population of mixed titration and tautomeric
states below 25% and 15%, respectively.
The microscopic reference pKa values of 4.0, 4.4, and 3.8 were used for
the Asp, Glu, and C-terminus carboxyl residues, respectively. This intro-
duced a positive error of 0.3 units when both the carboxylate oxygens
participated in the titration process (see Methods). Thus, we included a
correction that accounts for this and other errors that occur in the titration
simulations of model compounds in the reported pKa values for the test
proteins, OMTKY3 and RNase A (see the legends of Tables 3 and 5). For
histidine, the microscopic reference values of 6.6 and 7.0 were used for the
ND1- and NE2-titration, respectively. A correction that accounted for the
error in the titration of blocked histidine was included in the reported pKa
values for the histidines in RNase A (see Table 5 legend). The reference pKa
value of 7.5 was used for the N-terminus amino group.
Since the GBSWmodel was parameterized to closely mimic the solvation
energies from the ﬁnite-difference Poisson method, the optimized radii for
the latter method (29,30) were adopted to deﬁne the solvent-solute dielectric
boundary in the present work with some small modiﬁcations to better match
the experimental solvation free energies. Speciﬁcally, the solvation radii for
the oxygen atom in carboxylate, Tyr, Ser, and Thr residues were adjusted by
0.1, 0.1, 0.14, and 0.14 A˚, respectively.
Development of atomic radii for use with the GB model is a continuous
effort. Previous radii parameterizations for the PB methods were targeted
toward the experimental solvation energies of small molecules as well as the
calculated interaction energy of small molecules containing charged side
chains with explicit waters. However, this strategy is not ideal, for at least
two reasons. First, the solvation treatment of small molecules is not entirely
transferable to a protein environment. Second, reproducing the explicit
solvent behavior using the TIP3P (32), or any other explicit water model
carries along inherent problems of these models (33,34). Thus, current effort
in the group is directed toward reoptimization of the existing PB radii by
performing control GB simulations of model peptides and mini-proteins
aimed at ﬁnding the balance among stability, foldability, and the underlying
physical principles (31). Since the strength of the electrostatic interactions in
a microscopic approach such as the current CPHMD method is sensitive to
changes in solvation or desolvation energies, the accuracy of the constant pH
simulations will greatly beneﬁt from the improvement of the GB model.
In the current method, a ﬁxed set of solvation radii was used throughout
the titration simulations. This is a drawback, because the radii of ND1 and
NE2 on histidine in the GBSW model vary according to the charge state.
Although for the neutral state (HSD and HSE), the radius is 1.8 A˚, it is 0.5 A˚
larger in the charged state (HSP). A solution would be to linearly interpolate
the radius between these two states, which would, however, result in a devi-
ation from the quadratic behavior in the model potential function. Thus, in
the present work, we assumed a radius of 2.0 A˚ for ND1 and NE2 in the pH
range, expanding one unit below and one unit above the reference pKa value,
and the default radii for the neutral or charged states under other pH
conditions. Since the pKa values of carboxyl groups in OMTKY3 and RNase
A are a few units below that of the histidine, the error due to the ﬁxed
histidine radii approach is minor.
RESULTS AND DISCUSSION
Model compounds
Fig. 2 shows the two-dimensional potential of mean force
(PMF) maps for the blocked histidine and aspartic acid along
the titration and tautomer interconversion coordinates.
Notice that the PMF of the doubly protonated histidine
HSP (Fig. 2, A l ¼ 0) and the deprotonated aspartate (Fig. 2,
B, l ¼ 1) is constant. From the PMF map for histidine (Fig.
2, A), it is seen that the ND1-protonated form HSD (lower-
right corner where l ¼ 0, x ¼ 1) is higher in energy than the
NE2-protonated form HSE (upper-right corner where l¼ 0,
x ¼ 0). The barrier for HSP/ HSD is higher and occurs
later relative to that for HSP/HSE. From the PMF map for
the aspartic acid (Fig. 2, B), it is seen that the OD1-
protonated form ASP1 and OD2-protonated form ASP2 have
almost identical energy. The barriers for ASP1/ ASP and
ASP2/ ASP are very small (,5 kcal/mol, not visible in
Fig. 2) and occur very early in the deprotonation process.
FIGURE 2 Two-dimensional potential of mean force (PMF) map along
the titration coordinate l and tautomeric interconversion coordinate x for the
blocked His (left) and Asp (right) residues. The color bars shown on the right
indicate that the PMF increases from dark blue to dark red.
Constant pH Molecular Dynamics 147
Biophysical Journal 89(1) 141–157
Blocked histidine
Table 1 summarizes the running pKa values for the blocked
histidine using the double- and single-site titration models.
The pKa values were obtained from the data collected from
2-ns time windows along ﬁve 10-ns trajectories that were
initiated with random initial velocity seeds. Given the
reference pKa of 6.6 for the ND1 and 7.0 for the NE2
titration, the average running pKa values in the ﬁrst 2-ns
simulations have a deviation of 0.4 and 0.2 pK units for
the ND1- and NE2-titration, respectively. The associated
standard deviation due to different initial velocity seeds is
0.45 and 0.27 pK units for the ND1- and NE2-titration,
respectively. It is interesting to see that the error and standard
deviation in the single-site titrations remain approximately
constant over the entire 10 ns, suggesting the convergence of
the protonation state sampling. The greater variation from
the standard values and standard deviation in the ND1-
titration simulations can be attributed to an inherent problem
in the implicit solvent simulation of the charged histidine as
discussed further below.
Given the macroscopic pKa value of 6.45 (see Methods),
the error from the double-site titrations is ;0.35 pK units in
the 0–8-ns simulations and decreases to 0.15 in the last 2-ns
simulations. The standard deviation from the double-site
titrations is closer to that from the ND1-titrations in the ﬁrst
4-ns simulations and decreases almost steadily to 0.15 pK
units in the last 2-ns simulations. It is also interesting to
observe that the average pKa from the last 2-ns double-site
titrations (6.6) coincides with that obtained by combining the
pKa values from the two tautomer titrations (7.0 and 6.8)
using Eq. 22 from Methods, above. This suggests that with
sufﬁcient sampling of tautomeric states, the errors in the
double-site titrations mainly originate from those in the
single-site titrations, as will be seen in the titration simu-
lations of blocked aspartic acid.
As mentioned in Methods, the difference between the
solvation radii for ND1 and NE2 in the neutral and charged
states of histidine is 0.5 A˚. Since our approach uses a ﬁxed
set of radii for the l-dependent GB energy and force, the
protonation state whose assigned solvation radii are closer
to the ‘‘true’’ values (as given in the PB radii set; see Refs.
28,29) may be artiﬁcially favored. For example, in the
extreme case, if the true radius for the charged state HSP is
used in the single-site titration simulations, the titrating
nitrogen can become undersolvated resulting in a strong
electrostatic attraction between the titrating proton and the
partially negatively charged backbone carbonyl oxygen,
which prevents the deprotonation to occur. Curiously, this
has only occurred in titration simulations at the ND1 site. To
better understand this bias, we performed a standard GBSW
simulation of the blocked doubly protonated histidine. The
top plot of Fig. 3 shows that up until 1 ns of MD simulation,
the distance from the backbone oxygen to ND1 (solid) is
;3.4 A˚, which is .1 A˚ smaller than the distance to NE2
(shaded). At slightly after 1 ns, a conformational switch
occurs, leading to the merge of the ND1-O and NE2-O
distances. The middle plot of Fig. 3 shows a switch of the x1
dihedral angle from 50 to 59 at ;1 ns. The bottom plot of
Fig. 3 shows that the x2 dihedral angle remains approxi-
mately constant during the entire 2-ns simulation. Thus, the
difference in the electrostatic environment between the ND1
and NE2 provides an explanation for the failure of titration at
ND1. As the nitrogen radius for solvation is decreased to
2.0 A˚, both the ND1-O and NE2-O distances increase but
the former remains;1 A˚ smaller even after a conformational
switch occurs at 1 ns (data not shown).
In this work, we ﬁx the solvation radii at 2.0 A˚ for both
the neutral and charged states of histidine in the titration
simulation. Also, we restrict the pH range for the titration to
no more than 3 pK units, around the pH at which the
TABLE 1 Computed running pKa values for the blocked
histidine from the double- and single-site titration
simulations
0–2 ns 2–4 ns 4–6 ns 6–8 ns 8–10 ns
1 6.8 6.4 7.1 6.8 6.6
2 6.4 7.0 6.6 6.7 6.4
3 6.8 6.5 6.8 6.7 6.8
4 6.9 6.7 6.8 6.6 6.7
5 7.3 7.3 7.3 7.1 6.6
Mean (std.)* 6.8 (0.32) 6.8 (0.37) 6.9 (0.28) 6.8 (0.19) 6.6 (0.15)
ND1y 7.0 (0.45) 7.0 (0.39) 7.0 (0.40) 7.0 (0.48) 7.0 (0.53)
NE2y 6.9 (0.27) 6.8 (0.18) 6.8 (0.19) 6.8 (0.21) 6.8 (0.21)
The pKa values were obtained from 2-ns time windows with a total
simulation time of 10 ns at pH values 6, 7, and 8. An additional 100 ps was
allotted for equilibration. A random initial velocity seed was used for each
simulation run.
*Average and standard deviation of pKa values obtained from ﬁve double-
site titration simulations.
yAverage and standard deviations of pKa values obtained from ﬁve single-
site titration simulations.
FIGURE 3 2-ns standard GBSW simulation of the blocked doubly
protonated histidine. The top plot shows the time series of the distance from
the backbone carbonyl oxygen to ND1 (solid) and that to NE2 (shaded). The
middle and bottom plots show the time series of the x1 and x2 angles, re-
spectively.
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protonation state is expected to change. A rigorous way to
deal with the charge-state dependence of solvation radii is to
introduce some mixing scheme, for example, a linear inter-
polation of radii with respect to l. This is not implemented in
the current version of the CPHMD module, because it would
signiﬁcantly complicate the derivation of an analytic form
for the model potential function. As the CPHMD method
becomes more elaborated, one can envision the inclusion of
bonded parameters and solvation radii in the mixing scheme,
in which case the derivation of the model potential function
has to rely upon some numerical ﬁtting scheme.
Blocked aspartic acid
Table 2 summarizes the running pKa values for blocked
aspartic acid in the double-site and single-site titration
simulations. Given the target pKa of 4.3 (see Methods), the
double-site titrations lead to an underestimation of 0.5–0.6
pK units, with a standard deviation of 0.33 pK units in the
ﬁrst 2-ns simulation time. The magnitude of error and
standard deviation decreases as the simulation continues.
The last 2-ns gives an average error of 0.2 pK units with
a standard deviation of 0.25.
Table 2 also shows results from two types of single-site
simulations. First, simulations were conducted by keeping
the topology and bonded parameters (of the ionic aspartate,
see Methods, above) intact, while allowing only one
carboxylate oxygen (OD1 or OD2) to titrate. For titrations
at OD2 an average error of 0.3 pK units is observed for the
ﬁrst 2-ns simulations, the magnitude of which is reduced to
0.2 in the last 2-ns simulations. For titrations at OD1 there is
an average error of 0.1 pK units in the ﬁrst 2-ns simu-
lations. The standard deviations in the single-site simulations
are;0.1 pK units in the ﬁrst 2-ns simulations and are smaller
as the simulation progresses. A possible reason for the small
underestimation of the pKa value in the single-site titrations
is a slight overstabilization of the ionic aspartate relative
to the neutral aspartic acid due to insufﬁcient relaxation of
the peptide conformation in the latter state. In the titration
simulation, the residency time of the end-point states is on
the order of picoseconds (16), which is much smaller relative
to the length of the thermodynamic integration simulations at
discrete l-values (typically 1 ns) that were used to determine
the model potential function. Consequently, the employment
of the bonded parameters of the ionic aspartate that have two
C-O bonds with a formal bond order of 1.5 for both the ionic
and neutral states in the case of insufﬁcient sampling, can
slightly favor the ionic state leading to a negative error in the
predicted pKa value.
If the above explanation were true, it would predict
a positive error for single-site titrations using the bonded
parameters of the neutral aspartic acid that has one single and
one double C-O bond, as in the work of Lee et al. (16). This
is indeed the case. The last two rows of Table 2 show a
persistent overestimation by 0.2 pK units in the single-site
titrations at OD1 or OD2 using the force-ﬁeld parameters
that are designed for aspartic acid. The same single-site
model when used with the GBMV solvation method also
gave a overestimation of 0.3 pK units in the predicted pKa
(16). Notice that the single-site titrations using the force-ﬁeld
parameters for the neutral species exhibit standard deviations
twice those relative to using the parameters for the ionic
species. Based on the above considerations and given the
limitation of the current CPHMD methodology that allows
only single topology, titration simulations of carboxyl group
with the bonded parameters designed for the ionic species
seems to be a better choice. It should be noted that the
problem related to the force-ﬁeld parameters does not exist
in the titration simulations of histidine, since the latter has
identical bonded parameters for both charge states in the
CHARMM22 force ﬁeld.
OMTKY3
Table 3 summarizes the computed pKa values for turkey
ovomucoid third domain (OMTKY3) from the double-site
and single-site simulations and compares them with the
results from experiment and other simulations. The double-
site titration simulations with the crystal structure (column
Cryst.) yield an average absolute error of 1.0 pK unit based
on the ﬁrst 2-ns simulations and 1.2 pK units based on the
second 2-ns simulations. The double-site simulations with
the NMR structure (column NMR) yield pKa shifts (relative
to the model compound reference values) of the same sign
and the average absolute errors of similar magnitude. Thus
TABLE 2 Computed running pKa values for the blocked
aspartic acid from the double- and single-site titration
simulations (see legend below)
0–2 ns 2–4 ns 4–6 ns 6–8 ns 8–10 ns
1 3.9 3.5 4.2 4.3 4.3
2 3.4 3.5 4.1 4.0 4.2
3 3.7 3.7 3.7 3.9 3.7
4 4.3 4.5 4.7 4.2 4.3
5 3.8 3.1 3.4 3.8 4.0
Mean (std.)* 3.8 (0.33) 3.7 (0.52) 4.0 (0.50) 4.0 (0.21) 4.1 (0.25)
OD1y 3.9 (0.10) 4.0 (0.089) 4.0 (0.041) 4.0 (0.041) 4.0 (0.041)
OD2y 3.7 (0.12) 3.9 (0.055) 3.7 (0.045) 3.9 (0.083) 3.8 (0.083)
OD1z 4.2 (0.31) 4.2 (0.28) 4.2 (0.25) 4.2 (0.23) 4.2 (0.13)
OD2z 4.2 (0.34) 4.2 (0.28) 4.2 (0.31) 4.2 (0.23) 4.3 (0.23)
The pKa values were obtained from 2-ns time windows with a total
simulation length of 10 ns at pH values 3, 4, and 5. An additional 100 ps is
allotted for equilibration. A random initial velocity seed was used for each
run.
*Average and standard deviation of pKa values from ﬁve double-site
titration simulations.
yAverage and standard deviation of pKa values from ﬁve single-site
titration simulations using the bonded parameters for the ionic aspartate (see
text).
zAverage and standard deviation of pKa values from ﬁve single-site
titration simulations using the bonded parameters for the neutral aspartic
acid (see text).
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we do not observe a strong initial structure dependence to the
overall pKa comparisons. The single-site OD1 and OD2
titrations with the crystal structure (column OD1 (OD2))
result in pKa shifts of the same sign as from the double-site
simulations, but much larger average absolute errors (1.9 and
1.5, respectively). As expected, the magnitude of these errors
is similar to that from the single-site simulations with the
GBMV solvent model (column GBMV). Compared to
experimental data, the current simulations predict correct
signs of pKa shifts for all but one residue (Asp
27, see later
discussions), whereas the GBMV simulations predict only
one correct sign of the pKa shift (Glu
19). Finally, compared
to the CPHMD simulations, the two sets of PB calculations
employing a protein dielectric constant of 20 (column Static)
based on the static crystal structure yield smaller average
absolute errors (0.6 pK units).
To characterize the local electrostatic environment of
titrating residues in OMTKY3, Table 4 summarizes the dis-
tances among titrating residues from the double-site
simulations at three pH values and compares them with the
distances measured in the crystal structure. These three pH
values represent the conditions in which the speciﬁed residue
is fully protonated (acidic), partially protonated, or fully
deprotonated (basic). Below we will discuss the correlation
between the pKa value and the dominant electrostatic inter-
actions involving the titrating residue as revealed by the
simulations and the crystal structure data. In a related study,
Li et al. (35) showed that pKa values in OMTK3 could be
reproduced using QM methods with minimal models includ-
ing key interacting residues. It should be noted that since the
crystal structure was obtained under basic (pH ¼ 10) con-
ditions, where all carboxyl groups were deprotonated, the
measured distances between oppositely charged residues
represent lower bounds to those measured at lower pH.
Asp7 is a solvent-exposed residue that electrostatically
interacts mainly with Glu10 and Lys34. The positively
charged Lys34 provides stabilization for the ionic form of
Asp7. The crystal structure (Table 4) shows that Asp7 is
closer to Lys34 (5 A˚) than to Glu10, which explains the
downﬁeld pKa shift of the experimental pKa of Asp
7 relative
to the model compound value. Under acidic conditions
(pH ¼ 0, Asp7 is mainly neutral), Lys34 is further away from
Asp7 with the average distance of 6.3 A˚ and 7.1 A˚ in the ﬁrst
(0–2 ns) and second (2–4 ns) half of the simulation,
respectively. With increasing pH, the Asp7-Lys34 distance
becomes smaller. Under neutral conditions (pH ¼ 2), the
Asp7-Lys34 distance is 6.6 A˚ and 5.3 A˚ in the ﬁrst and second
half of the simulation, respectively. Under more basic
conditions (pH ¼ 4, Asp7 is mainly ionized), a salt bridge is
formed between Asp7 and Lys34: the average distance is
4.0 and 3.8 A˚ in the ﬁrst and second half of the simulation,
respectively. The lower pKa value (pKa ¼ 2.4) of Asp7 in the
second half of the simulation relative to that in the ﬁrst half
(pKa ¼ 2.8) is mainly due to the additional electrostatic
attractions from Arg21, which moves on average;5 A˚ closer
to Asp7 in the second half of the simulation. In contrast to the
Asp7-Lys34 distance, the Asp7-Arg21 distance becomes
larger at pH 4.
The pKa (2.8) for Asp
7 obtained from the ﬁrst 2-ns simu-
lations using the double-site model is between the values
computed using the OD1 (pKa ¼ 3.9) and OD2 (pKa ¼ 1.9)
single-site model, and agrees well with the experimental
value of 2.7 (Table 3). This is consistent with the reasonable
agreement of the simulated major electrostatic interactions
(Asp7 with Glu10 and Lys34) under basic conditions with
those from experiment (crystal structure).
The electrostatic environment of Glu10 is more complex,
and includes the titratable groups Asp7, Lys13, Arg21, and
Lys34 (Table 4). In the crystal structure, Lys13 is the closest
residue with the Lys13-Glu10 distance of 4.8 A˚, followed by
Lys34, Asp7, and Tyr11, that are.6 A˚ away. Arg21 is;18 A˚
from Glu10 in the crystal structure. In contrast, MD simu-
lations under neutral to basic conditions show that Arg21
moves to be ,7 A˚ away from Glu10 (Table 4).
The top plot of Fig. 4 shows how the motion of Glu10 is
correlated with that of Asp7, Lys34, and Arg21 at pH 3, where
Glu10 is partially deprotonated. At the beginning of the
simulation, Lys34 is in salt-bridge contact with Glu10 (dashed
curve) and is ;6.5 A˚ away from Asp7. Due to the attractive
electrostatic force and the diminished mobility of Lys34,
Asp7 is driven closer to form a salt bridge with Lys34 at
;320 ps (shaded dashed curve), which also results in a sharp
TABLE 3 Computed pKa values for OMTKY3
(see legend below)
Residue Cryst. NMR OD1 (OD2) GBMV Static Expt.
Asp7 2.8 (2.4) 3.2 (3.2) 4.0 (1.9) 4.5 2.9 (2.9) ,2.7
Glu10 3.1 (2.3) 2.6 (2.6) 2.5 (2.7) 5.1 3.4 (3.4) 4.2
Glu19 2.3 (2.1) 2.6 (2.5) ,0.0 (0.7) 2.7 3.2 (2.6) 3.2
Asp27 4.7 (4.7) 4.0 (3.9) 5.0 (4.6) 6.1 4.0 (3.6) ,2.3
Glu43 5.3 (5.5) 4.3 (4.6) 4.1 (4.5) 6.0 4.3 (4.4) 4.8
CT-Cys 1.3 (1.8) 1.0 (1.3) 0.9 (1.0) 4.6 2.7 (2.5) ,2.5
Avg. abs. error* 1.0 (1.2) 1.1 (1.0) 1.9 (1.5) 1.7 0.6 (0.6) —
The pKa values were obtained from 4-ns simulations of OMTKY3 at pH
values 0, 1, 2, 3, 4, 5, and 6. An additional 200 ps was allotted for
equilibration. Unless otherwise noted, the pKa values obtained from 2-4 ns
simulation time are listed in parentheses next to those from 0 to 2 ns. A
value of 0.3 was added to all the pKa values from the double-site
simulations to correct the errors found in the model compound simulations
(see Table 2). For the same reason, the computed pKa values from the
single-site titrations were corrected by adding 0.1 and 0.3, respectively (see
Table 2). The double-site titrations were based on the crystal structure
PDB:1PPF (44) (column Cryst.) or the ﬁrst entry of the NMR structure
ensemble PDB:1OMU (45) (column NMR). Column OD1 (OD2) refers to
the 2-ns single-site titration at either OD1 or OD2, with the bonded
parameters of the ionic aspartate. Column GBMV refers to the 1-ns single-
site (OD2) simulations with the GBMV solvation model (16). Column
Static refers to the static PB calculations of Forsyth et al. (46) and
Antosiewicz et al. (in parentheses) (38) using the same crystal structure.
Protein dielectric constant was set to 20 in these calculations. Column Expt.
refers to the experimental data taken from Schaller and Robertson (47).
*Average absolute deviations from experimental data. The upper limit is
used when a range is given.
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drop in the Asp7-Glu10 distance from 9 A˚ down to below 6 A˚
(solid curve). However, this local environment is not stable,
due to the electrostatic repulsion between Asp7 and Glu10. At
the same time, the electrostatic attraction between Arg21 and
Glu10 facilitates the departure of Glu10 from Lys34 and the
formation of a loose salt-bridge contact between Glu10 and
Arg21 at 450 ps (dotted curve), which then breaks off at
520 ps due to the motion of Glu10. The dynamics in the fol-
lowing period of time (until the end of the ﬁrst half of the
simulation), is dominated by the motion of Glu10, driven by
the attraction from Lys34 and Arg21. This continues at the
beginning of the second half of the simulation and starting at
;1.1 ns, Glu10 arrives at a position that allows it to form salt-
bridge contacts with both Lys34 and Arg21, although not as
tight as the Lys34-Asp7 salt bridge. The dynamics of the last
part of the simulation (between 1.6 and 2 ns) is again char-
acterized by the breaking and making of the electrostatic
contacts of Glu10-Lys34 and Glu10-Arg21.
A comparison of the bottom plot of Fig. 4 with the top one
shows a direct correlation between the unprotonated fraction
of Asp7 (solid curve), that of Glu10 (dashed curve), and the
existence of the salt bridge. Accordingly, Asp7 is protonated
at the beginning of the simulation and becomes unprotonated
once it forms and maintains the salt bridge with Lys34. On
the other hand, Glu10 is unprotonated at the beginning and
becomes protonated upon its departure from both Lys34 and
Arg21. In the second half of the simulation it looses a proton
again due to salt-bridge formation with Lys34 and Arg21.
Finally, the simultaneous loss of salt-bridge contacts between
Glu10 and Lys34 and between Glu10 and Arg21 is reﬂected in
the plot as a dip in the curve of the unprotonated fraction.
Fig. 4 also reveals that the salt-bridge formation in the
second half of the simulation is the cause for the lowering of
Glu10’s pKa relative to the ﬁrst half of the simulation,
consistent with the observation for Asp7.
TABLE 4 Distances between titrating residues and other charged residues in OMTKY3 (see legend below)
Cryst.
Asp7 pH ¼ 0 pH ¼ 2 pH ¼ 4
Glu10 11.0 (1.9) 6.4 (1.0) 7.2 (1.8) 6.6 (1.1) 7.6 (1.6) 6.8 (0.8) 6.7
Arg21 10.7 (1.3) 12.1 (0.9) 11.9 (2.1) 6.8 (3.0) 8.8 (1.5) 9.7 (1.3) 17.4
Lys34 6.3 (0.7) 7.1 (1.1) 6.6 (1.4) 5.3 (1.7) 4.0 (0.9) 3.8 (0.6) 5.0
Glu10 pH ¼ 1 pH ¼ 3 pH ¼ 5
Asp7 7.3 (1.8) 6.8 (1.6) 8.3 (1.4) 6.7 (1.1) 8.5 (2.5) 6.5 (0.6) 6.7
Lys13 4.6 (0.9) 4.7 (0.9) 7.4 (2.2) 7.2 (2.6) 7.8 (2.4) 9.6 (1.2) 4.8
Arg21 12.5 (2.2) 11.1 (2.6) 7.3 (2.0) 5.1 (1.5) 6.8 (1.6) 5.8 (0.9) 18.2
Lys34 6.8 (1.5) 6.5 (1.8) 6.0 (2.7) 4.6 (1.6) 4.4 (1.9) 3.4 (0.3) 6.3
Glu19 pH ¼ 1 pH ¼ 2 pH ¼ 4
Lys13 6.7 (1.0) 6.4 (1.4) 8.2 (1.9) 7.2 (2.0) 12.2 (1.6) 13.0 (1.4) 10.3
Arg21 9.7 (1.8) 6.9 (2.3) 9.2 (2.0) 7.9 (1.1) 4.5 (1.1) 4.2 (0.5) 8.6
Lys34 7.4 (1.7) 7.6 (1.7) 6.8 (1.8) 4.4 (1.3) 8.3 (1.6) 9.6 (1.2) 10.7
Asp27 pH ¼ 2 pH ¼ 4 pH ¼ 6
Lys29 6.6 (0.7) 6.5 (1.1) 4.6 (1.1) 6.7 (1.1) 6.8 (1.7) 5.7 (1.7) 6.1
Tyr31 5.0 (0.7) 5.2 (0.9) 4.9 (0.8) 4.7 (0.6) 5.3 (1.0) 5.4 (1.1) 3.5
CT-Cys pH ¼ 0 pH ¼ 2 pH ¼ 3
His52 4.8 (0.6) 4.6 (0.6) 4.6 (0.6) 4.6 (0.6) 4.3 (0.6) 4.3 (0.6) 4.9
Lys55 9.0 (0.5) 9.1 (0.2) 8.9 (0.8) 8.5 (1.5) 8.8 (1.3) 9.2 (0.4) 7.9
Average and RMS ﬂuctuations of distances (in A˚) between the titrating and other charged residues in the ﬁrst (0–2 ns, left column) and second half (2–4 ns,
right column) of the simulations of OMTKY3 starting from the crystal structure PDB:1PPF (44), under three pH conditions. The pH values represent the
conditions in which the speciﬁed residue is fully protonated (left), partially protonated (middle), and fully deprotonated (right). Only those distances smaller
than 10 A˚ are shown. For Asp27, Tyr31 is listed since it forms a hydrogen bond with Asp27 in the crystal structure (see text). The residue-residue distance is
deﬁned as that to the carboxyl carbons, NE2 of histidine, NZ of lysines, and CZ of arginines. The column Cryst. refers to the distances measured in the crystal
structure at pH 10.
FIGURE 4 Coupling between Asp7 and Glu10 in a 2-ns simulation of
OMTKY3 at pH 3. The top plot shows the time series of the running average
distances between Asp7 and Glu10 (solid), Asp7 and Lys34 (shaded dashed),
Glu10 and Lys34 (dashed), and Glu10 and Arg21 (dotted) computed from 100-
ps time windows. The deﬁnitions of the residue-residue distances are given
under Table 4. The bottom plot shows the running unprotonated fraction for
Asp7 (solid) and Glu10 (dashed) computed from 100-ps time windows.
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In contrast to the simulation, which reveals two on and off
salt bridges (Glu10Lys34 and Glu10Arg21), the crystal
structure shows only one salt bridge (Glu10Lys13). This is
the reason for the negative difference (1.1 pK units) in the
computed pKa for Glu
10 relative to experiment. In the last
2-ns simulations, the simultaneous formation of the two salt
bridges gives rise to a larger difference (1.9 pK units)
relative to the ﬁrst 2-ns simulations (1.1 pK units). The
salt-bridge effects seem to be more pronounced in single-site
titrations. As a result, the differences are larger: 1.8 for the
OD1 and 1.5 pK units for the OD2 titrations. Interestingly,
the PB calculation also gives an underestimation of 0.8 pK
units.
In the crystal structure under basic conditions, Glu19
interacts with three positively charged groups (Lys13, Arg21,
and Lys34) at a distance over 8 A˚ (Table 4). However, in the
simulation at pH .2, Glu19 forms a persistent salt bridge
with Arg21, thereby preventing the protonation of Glu19.
This is the reason for the negative difference of Glu19’s pKa
(0.9 pK units) using the double-site simulations (Table 3)
relative to experiment. The magnitude of the underestimation
using the OD1 and OD2 titrations is ;2 pK units larger.
The prediction of the pKa for Asp
27 is most problematic,
since it is partially sequestered from solvent and yet it is the
most acidic residue in OMTKY3 according to experiment
(Table 4). In the simulation at pH 4, Asp27 is a hydrogen-
bond acceptor to its backbone amide nitrogen and to that of
Lys29 with an occupancy of 20%. In addition, Asp27 interacts
with the hydroxyl oxygen of Tyr31 as both a hydrogen-bond
acceptor and donor with an occupancy of 30%. In the ﬁrst
2-ns, Asp27 is .40% deprotonated due to the salt-bridge
interaction with Lys29 (Table 4). Although the mobility of
Asp27 is low, the ﬂuctuation of the side-chain position of
Lys29 is large as seen from the .1 A˚ root-mean square
(RMS) deviation of the Asp27-Lys29 distance. In the last
2-ns, Asp27 loses the salt-bridge contact with Lys29 and dom-
inantly occupies the protonated state (Table 4). The con-
vergence of the protonation state sampling for Asp27 is
incomplete, which can be seen from a large percentage of
mixed states (;36% in the ﬁrst and 42% in the last 2-ns of
simulation time).
The double-site titration model overestimates the pKa for
Asp27 by 2.4 pK units, the largest error among all the
residues in OMTKY3 (Table 3). Interestingly, Asp27 shows
the largest computational error in the static PB calculations
as well, although to a lesser degree (overestimated by 1.7 and
1.3 pK units). As compared to the single-site model, the
double-site model does not offer any advantage for the
titration of Asp27. One obvious reason for the large deviation
from experiment is the aforementioned issue of incomplete
sampling of protonation states. Conformational relaxation of
buried residues in response to ionization requires much
longer simulation time as demonstrated in a recent work by
Simonson et al. (36). Another possible reason for the differ-
ence may be the overestimation of the desolvation effect due
to undersolvation for the protonated aspartic acid relative to
the charged aspartate, since the current GB model employs
one atomic solvation radius for the both the neutral and
charged forms.
Glu43 does not have strong electrostatic interactions with
other charged groups and has therefore a small experimental
pKa upshift of 0.4 units (Table 3). Although the OD1 and
OD2 titrations give a downshift of 0.4 and a upshift of 0.1 pK
units, respectively, the double-site model predicts an upshift
of 0.9 units, consistent with the experimental values. The
deviations from experiment are within statistical errors, as
shown in the titration simulations for model compounds.
Interestingly, the static PB calculation is unable to capture
the sign of the experimental pKa shift of Glu
43.
The local electrostatic environment around the a-carboxyl
group CT-Cys includes two positively charged residues
His52 and Lys55 (Table 4). The pKa downshift of CT-Cys is
dominated by the interaction with His52, since the simulation
data reveals the formation of a salt bridge between CT-Cys
and His52 that does not exist in the crystal structure (Table 4).
This explains why the double-site simulations result in a pKa
downshift that is 1.2-pK-units greater relative to experiment
and the single-site titrations yield even larger errors.
RNase A
Bovine pancreatic ribonuclease A (RNase A) is an enzyme
that catalyzes the transphosphorylation and hydrolysis
reactions of RNAs (37). Table 5 summarizes the computed
pKa values from the double-site simulations with the GBSW
solvation model (current model), in comparison with the
split-model simulations (imidazole ring is split into two
titration halves involving ND1 and NE2) with the GBMV
solvation model (previous work) (16), and the PB static
calculations (38), as well as experimental data. The current
model gives an average absolute error of 0.6 pK units for the
histidine groups, representing a signiﬁcant improvement
over the previous work using the split-model (2.5 pK units).
In fact, the error from the current model is even smaller than
that from the static PB calculations (0.8 pK units). It is
noteworthy that results from the split-model simulations with
the GBSW solvation model yield even larger differences
(data not shown). The current model also gives smaller
average absolute error (1.6 pK units) for the carboxyl groups
relative to the previous work (2.0 pK units). For the
N-terminus group, the current model yields a difference of
0.6 pK units, as compared to 1.0 pK unit from the previous
work. Again, the current model predicts the correct sign for
all pKa shifts in RNase A, in contrast to the previous work
that predicts the correct sign for only seven pKa values
(with a total of 17).
The protonation equilibria of active-site residues His12 and
His119 are responsible for the pH-dependent catalytic mech-
anism of RNase A. A traditional view is that His12 and His119
act as general acid and base in RNA hydrolysis, respectively,
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whereas their roles are reversed in the transphosphorylation
step (37). The crystal structure of the phosphate-free RNase
A (PDB:7RSA, see Ref. 39; pH ¼ 5.3), shows that His12 is
completely buried whereas His119 is partially buried in the
protein interior. Thus, desolvation effects are expected to
result in their pKa downshifts. Distance measurements in the
crystal structure reveal an electrostatic interaction between
His12 and His119 and a hydrogen bond between the NE2 of
His119 and OD1 of Asp121 (Table 6).
The lower plot of Fig. 5 shows that His12 is predominantly
charged in the ﬁrst half of the simulation (0–1 ns), and
switches to be in the neutral state in the second half of the
simulation (1–2 ns) under pH 5 conditions. On the other
hand, the degree of deprotonation of His119 ﬂuctuates at
;0.5 in the ﬁrst half of the simulation but becomes much
smaller in the second half of the simulation. Fig. 5 also
reveals that the degree of deprotonation on His12 and His119
is correlated with the strength of the electrostatic interaction
between them. As His12 and His119 are .7 A˚ away from
each other between 400 and 600 ps, the interaction is small,
allowing both residues to be in the charged state at pH 5. As
His119 moves closer to His12 between 750 and 1000 ps,
His119 starts to lose its proton more often. As the distance
continues to shorten, the coupling between His12 and His119
is so strong that only one residue (His119) is allowed to be
charged to minimize the electrostatic repulsion. Thus, the
strong coupling raises the pKa of His
119 and lowers that of
His12. The upper plot of Fig. 5 reveals that the ﬂuctuation in
the His12-His119 distance is linked to the change in the x2
TABLE 5 Calculated pKa values for RNase A
(see legend below)
Residue This work Lee Static Expt.
NT-Lys 7.2 6.6 7.0 7.6
Glu2 0.0 ,1.0 2.5 2.8
Glu9 2.6 5.8 4.1 4.0
His12 5.1 2.8 4.3 6.2
Asp14 3.1 3.5 2.0 2.0
Asp38 1.5 2.4 2.8 3.1
His48 6.3 7.7 6.5 6.0
Glu49 5.0 6.4 4.6 4.7
Asp53 3.8 4.5 3.6 3.9
Asp83 0.9 7.4 2.1 3.5
Glu86 3.9 5.9 3.8 4.1
His105 7.3 10.8 6.2 6.7
Glu111 3.7 5.8 3.9 3.5
His119 5.7 7.5 6.5 6.1
Asp121 0.4 3.3 1.3 3.1
CT-Val 0.0 ,1.0 2.3 2.4
Avg. abs. error* 1.6 2.0 0.5
Avg. abs. errory 0.6 2.7 0.8
Abs. errorz 0.4 1.0 0.6
The pKa values were obtained from 2-ns simulations of RNase A at a pH
range between 0 and 8 with an increment of 1 using the crystal structure
PDB:7RSA (39).To correct the errors found in the model compound
simulations a value of 0.4 was subtracted from the computed pKa values for
His105, and His119 whereas 0.1 was added to the computed pKa values for
His12 and His48 since they titrate via NE2 exclusively (see Table 1). For the
same reason, the computed pKa values were corrected by adding 0.3 units
for all the carboxyl residues except for Asp53, in which case 0.1 units was
added to the computed value since it titrates via OD1 exclusively (see Table
2). Column Lee refers to the work of Lee et al. (16). Column Static refers to
the static PB calculations of Antosiewicz et al. (38) using a protein
dielectric constant of 20. Cited are the values averaged over the calculations
which allow the protonation of histidine to occur at either NE2 or ND1 and
with His119 being in the crystal conformation A. Column Expt. refers to the
experimental data cited in the work of Antosiewicz et al. (38).
*Average absolute error of the computed pKa values for the carboxyl
residues.
yAverage absolute error of the computed pKa values for the histidine
residues.
zAbsolute error of the computed pKa for NT-Lys.
TABLE 6 Distances between histidine residues and other
nearby residues in RNase A (see legend below)
Cryst.
His12 pH ¼ 4 pH ¼ 5 pH ¼ 7
r(NE2ND1119) 4.3 (1.0) 4.8 (1.2) 3.9 (0.9) 6.3
His48 pH ¼ 4 pH ¼ 6 pH ¼ 8
r(ND1CG14) 3.8 (0.3) 4.1 (0.3) 7.1 (0.8) 4.3
r(ND1O14) 3.3 (0.5) 3.7 (1.2) 4.1 (1.1) 3.3
His105 pH ¼ 5 pH ¼ 7 pH ¼ 8
r(ND1O75) 4.8 (0.7) 4.1 (0.9) 4.1 (1.0) 3.0
r(NE2O76) 3.6 (0.6) 3.8 (0.6) 4.0 (0.6) 4.6
His119 pH ¼ 4 pH ¼ 5 pH ¼ 8
r(NE2OD1121) 4.0 (1.1) 5.3 (2.0) 7.1 (1.0) 1.9
Average and RMS ﬂuctuations of the distances (in A˚) between the histidine
and other strongly interacting residues in the 2-ns simulations of RNase A
starting from the crystal structure PDB:7RSA (38) under three pH
conditions. The pH conditions are arranged such that the left and right
ones give the fully protonated and deprotonated states, respectively,
whereas the middle one gives partial protonation/deprotonation. The atoms
used in the distance measurements are speciﬁed in parentheses, where the
ﬁrst atom refers to the underlined residue and the second one is indicated by
the superscript. The column Cryst. refers to the distances measured in the
crystal structure at pH 5.3.
FIGURE 5 Coupling between His12 and His119 in a 2-ns simulation of
RNase A at pH 5. The top plot shows the time series of the distance between
NE2 of His12 and ND1 of His119. The bottom plots shows the running
fraction of neutral states for His12 (solid) and His119 (dashed) computed
from 100-ps time windows.
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dihedral angle of His119. In contrast, His12 has a much lower
mobility since it is buried and subject to steric hindrance
from neighboring groups.
Another factor that affects the ionization equilibrium of
His119 is its interaction with Asp121, which is a hydrogen-
bond acceptor according to the crystal structure. In the
simulation the hydrogen bond NE2-HE2119OD1121 only
exists under pH conditions below 5. At pH 5, His119
becomes partially deprotonated and the average distance
between NE2119 and OD1121 is 5.3 A˚ (Table 6). The loss of
the hydrogen-bonding interaction with Asp121 contributes to
the stronger interaction between His119 and His12, relative to
that observed in the static crystal structure. This could arise
from the ﬁxed atomic solvation radii used in the current
simulation. At pH 5, His119 in the charged state experiences
less attraction from Asp121 due to the enhanced solvent
screening as a result of the smaller solvation radius. On the
other hand, the enhanced solvent screening decreases the
unfavorable interaction between His119 and His12. It should
be noted, however, that the degree of the enhanced solvent
screening is small, since both the NE2 and ND1 atoms are
partially sequestered from solvent.
The interaction between His119 and His12 is one reason for
our underestimation of the pKa for His
12. It may also be linked
to the exaggerated desolvation effect, which can be again
partially attributed to the ﬁxed atomic solvation radii approx-
imation. In this case, the neutral state is preferentially sta-
bilized, as a result of a larger desolvation penalty for the
charged state. It is interesting to see that the static PB calcu-
lation also gives a large underestimation for the pKa of His
12.
The current simulations reveal that whereas the deproto-
nation process of His119 occurs via both ND1 and NE2
atoms, the deprotonation of His12 occurs predominantly
(.90%) at NE2 (data not shown). This is in agreement with
a direct observation via the high-resolution x-ray diffraction
of RNase A (sulfate bound) under different pH conditions
(39) and is in support of the proposed mechanism, which
suggests that the NE2 atom of His12 exchanges a proton with
the substrate (40). It is worthwhile emphasizing the im-
portance of predicting the correct tautomeric state for the
histidine titration. The PB calculation and the split-model
simulation gave a signiﬁcant underestimation of His12’s pKa
by 2.0 and 3.4 units, respectively.
His119 has two conformations due to the variation in the
x1 dihedral, which are referred to as trans and gauche. In the
above experimental study (40) both conformations were
observed at the acid pH (pH ¼ 5.2), whereas only the trans
conformation was observed at the basic pH (pH ¼ 8.8). The
current simulations, however, show that the trans confor-
mation exists exclusively in the pH range between 5 and 8.
This is in line with the argument put forward by the authors
that the coexistence of both conformations is made possible
through hydrogen bonding with the sulfate ion whereas the
trans conformation is favored in the ion-free environment
due to its strong interaction with Asp121 (40).
His48 is completely embedded in the protein interior and
interacts with a nearby negatively charged embedded residue
Asp14. Thus, the protonation equilibrium ofHis48 is a result of
the balance between the desolvation effect that favors the
neutral state and the electrostatic interaction that favors the
charged state. In fact, the experimental pKa reveals only a
small downshift. The simulation at pH 6 (partial deprotona-
tion) shows that the charged state of His48 is stabilized by
a salt-bridge interaction with Asp14, as well as the hydrogen
bond between HD1 of His48 and the backbone carbonyl
oxygen ofAsp14 (Table 6). Thus, it appears that theND1 atom
is protected from deprotonation through its hydrogen bonding
with Asp14. This is consistent with the observation made in
the aforementioned experiment that the deprotonation of
His48 occurs via its NE2 atom (40). As His48 becomes depro-
tonated, the current simulations show that the x2 dihedral
angle changes from an average of 61 (pH ¼ 6) to an
average of 53 (pH ¼ 8), in line with the experimental
observation (40).
It is curious that His105 exhibits an error of 0.6 units for its
computed pKa, although it is fully immersed in solvent and
free of strong electrostatic interactions with other charged
residues. A close examination of the MD trajectory at pH 7
(partial deprotonation) reveals occasional hydrogen-bonding
contacts between its HD1 atom and the backbone carbonyl
oxygen of Ser75 with an occupancy of 24%, as well as be-
tween the HE2 atom and the backbone carbonyl oxygen of
Tyr76 with an occupancy of 13%, which do not exist in the
crystal structure (Table 6). Consequently, the doubly pro-
tonated form of His105 is stabilized resulting in an over-
estimation of its pKa unit relative to experiment (Table 5).
From Table 5 it can be seen that the average absolute error
of the computed pKa values for RNase A is dominated by
four groups, Glu2, Asp83, Asp121, and CT-Val. The pKa
downshifts for these groups are calculated to be too large by
2.8, 4.4, 2.7, and 2.4 units relative to the corresponding
experimental values, respectively. Table 7 summarizes the
computed distances between these and other nearby charged
residues in comparison to the measured values. It should be
noted that since the crystal structure was obtained at pH 5.3,
where all carboxyl groups are deprotonated, the measured
distances between the oppositely charged residues represent
lower bounds to the distances measured at lower pH.
The protonation equilibria of Glu2 and Asp38 are coupled.
Both the crystal structure and simulation at pH 0 show that the
ionic form of Glu2 is stabilized through two charged
hydrogen bonds to Arg10: OE1 with NH2 and OE2 with NE
(Table 7). The simulation also reveals a slightly closer dis-
tance of Glu2-Lys7 relative to experiment. As pH is increased
to 2, the simulation shows that whereas the double hydrogen
bonds between Glu2 and Arg10 are maintained, Asp38 moves
closer toArg10 and forms a charged hydrogen bond to Arg10’s
NH2 via its carboxylate oxygens alternately (Fig. 6 A). In
contrast to the strong interaction between Asp38 and Arg10 as
revealed by simulation results, the crystal structure shows
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a salt bridge between Asp38 and Lys37 (Table 7). Thus, it
appears that the simulation overestimates the strength of the
electrostatic interaction between a negatively charged residue
and arginine.
The prediction of the pKa for Asp
83 seems to be most
problematic due to its interaction with Arg85. The crystal
structure shows that Arg85 occupies two conformations with
its amino groups either pointing toward or swinging away
from the carboxyl group of Asp83. In the former case, a salt
bridge is formed between OD2 of Asp83 and NH2 of Arg85.
However, independent of the starting conformation, the
simulation leads to two charged hydrogen bonds between the
carboxylate oxygens of Asp83 and the hydrogens that are
attached to the NE and NH2 atoms of Arg85 (Fig. 6 B) within
just a few hundreds of picoseconds.
The charged hydrogen bonding triad plays a major role
in the protonation equilibria of Asp121 and CT-Val. The
simulation at pH 0 shows that Asp121 is a hydrogen-bond
acceptor to the backbone amide of Lys66 via OD1 and to the
NE2 atom of His119 via OD1 (Fig. 6 C). In contrast, the
crystal structure shows only salt-bridge interactions between
Asp121 and Lys66 and between Asp121 and His119 (Table 7),
although it has been suggested in other experimental work
that the hydrogen bond between Asp121 and the backbone of
Lys66 was used to restrict the conformational entropy of the
protein (41). Similarly, the simulation at pH 0 shows that
CT-Val is a hydrogen-bond acceptor to the backbone amide
of His105 via OT1 that occasionally accepts a hydrogen bond
from the NZ atom of Lys104 (Fig. 6 D). Interestingly, the
backbone amide of CT-Val is hydrogen bonded with the
backbone carbonyl of His105 as well (Fig. 6 D).
CONCLUDING REMARKS
In this work, we have presented a two-dimensional l-dynam-
ics approach to include proton tautomerism in continuous
constant pH molecular dynamics (CPHMD) simulations.
Consequently, a new tautomeric state model, also called the
double-site titration model, is constructed for titration simu-
lations involving histidine and carboxyl residues.
The double-site titration model combined with the GBSW
solvationmethod was tested on blocked histidine and aspartic
acid. Given sufﬁcient sampling of tautomeric and protonation
states, our calculations give good quantitative estimates of
site-speciﬁc pKa values. Sources of deviation in the titration
simulations of blocked histidine and aspartic acid are the
ﬁxed-radii approximation, the use of the same bonded param-
eters for both the neutral and charged states, and sampling
convergence of conformational variables. These issues rep-
resent areas of continuing improvement of such models.
The results of the CPHMD simulations using the double-
site titration model and the GBSW solvation method are very
encouraging and provide a signiﬁcant improvement over the
previous work. In contrast to the single-site model with the
TABLE 7 Distance between the carboxyl residues and other
nearby charged residues in RNase A (see legend below)
Cryst.
Glu2 pH ¼ 0
r(CDNZ7) 6.8 (1.3) 7.3
r(OE1NH210) 3.5 (1.5) 2.8
r(OE2NE10) 3.9 (1.6) 2.8
Asp38 pH ¼ 2
r(CGCZ10) 6.2 (2.8) 10.3
r(CGNZ37) 7.9 (1.9) 4.1
r(CGCZ39) 6.8 (1.3) 8.2
Asp83* pH ¼ 0
r(OD1NE85) 2.9 (0.5) 6.6
r(OD2NH285) 2.9 (0.2) 3.1
Asp121 pH ¼ 0
r(OD1N66) 3.8 (1.0) 3.7
r(OD2N66) 3.8 (1.0) 2.8
r(OD1NE2119) 4.5 (1.7) 2.9
CT-Val pH ¼ 0
r(OT2NZ104) 4.3 (0.9) 4.7
r(OT1N105) 2.9 (0.3) 5.0
r(NO105) 2.8 (0.1) 2.9
Average and RMS ﬂuctuations (in A˚) between the carboxyl residues that
exhibit large errors in the calculated pKa values (.1.5 pK units) and other
nearby charged residues in the 2-ns simulations of RNase A starting from
the crystal structure PDB:7RSA (39) under a pH condition that gives partial
protonation/deprotonation. The atoms used in the distance measurements
are speciﬁed in parentheses, where the ﬁrst atom refers to the underlined
residue and the second one is indicated by the superscript. Column Cryst.
refers to the distances measured in the crystal structure at pH 5.3.
*Taken from the crystallographic conformation where Arg85 is pointing
toward Asp83 (see text).
FIGURE 6 Snapshots from the 2-ns simulation of RNase A showing the
salt-bridge and hydrogen-bond interactions involving Glu2, Asp83, Asp121,
and CT-Val under pH conditions of 2, 0, 0, and 0, respectively.
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GBMV solvation, the new model predicts the right sign for
all the pKa shifts but one in the benchmark proteins. The new
model offers a striking accuracy in the prediction of the
protonation and tautomeric states of the histidine residues in
RNase A.
However, our detailed analyses of the pH-dependent
dynamics of the local electrostatic environment in OMTKY3
and RNase A point to potential areas for improvement of the
underlying solvation model to ameliorate the undersolvation
of salt bridges. This factor may account for the systematic
underestimation of the pKa values for carboxyl residues that
interact with positively charged residues in solvent. The
overstabilization of salt bridges in the context of continuum
electrostatics is a known problem in the community of protein
simulations. One remedy, as used in the work of Georgescu
et al. (42), is to introduce some empirical function to dampen
the ion-pair interactions. A straightforward but perhaps less
pragmatic approach is to reoptimize the atomic solvation radii
aiming for a balance among protein stability, foldability, and
the underlying physical principles.
Conformational and protonation state sampling also
inﬂuence the quantitative accuracy of calculated pKa values,
especially for coupled titrating residues such as His12 and
His119 in RNase A and buried residues such as Asp27 in
OMTKY3. The CPHMD approach will clearly beneﬁt from
the introduction of more efﬁcient sampling techniques, such
as replica-exchange MD (43). Our ﬁndings, nevertheless,
clearly indicate that environmentally dependent factors, and
their ﬂuctuating character, mediate the protonation/deproto-
nation processes for such systems coupled to a pH bath.
One of our main goals in the development of the CPHMD
technique is to model important pH-triggered conformational
phenomena of proteins, such as the pH-dependent folding/
unfolding, membrane insertion, ligand binding, and cataly-
sis. Using OMTKY3 and RNase A, the current work has
demonstrated in detail the capability of the CPHMD tech-
nique in revealing the pH-coupled conformational dynamics
of protein side chains. Future work will include the devel-
opment of more elaborate mixing schemes, which improve
the representation of the l-dependence in computing sol-
vation energy, covalent interactions, and the addition of more
complex sampling schemes.
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